Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer
    Meeting Abstract

    Mondaca, S.; Schultz, N.; Roa, J. C.; Walch, H. S.; Sepulveda, S.; Harding, J. J.; Yaqubie, A.; Garcia, P.; Aguayo, G.; Nervi, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Relationship between diabetes and its severity, frailty and adverse surgical outcomes among older adults with cancer
    Meeting Abstract

    Martes, J.; Tin, A. L.; Shahrokni, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211)
    Meeting Abstract

    Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Gene expression of vitamin D (VitD) pathway markers and survival in patients (Pts) with metastatic colorectal cancer (mCRC): CALGB/SWOG 80405 (Alliance)
    Meeting Abstract

    Kohn, C. G.; Ou, F. S.; Ma, C.; Larson, N. B.; Zemla, T. J.; Yuan, C.; Niedzwiecki, D.; Hollis, B. W.; Nixon, A. B.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors
    Meeting Abstract

    Kelley, R. K.; Van Cutsem, E.; Lee, M. S.; Wolf, I.; Fakih, M.; De Vos-Geelen, J. D.; Lee, V.; Vogel, A.; Wu, L.; Jin, F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC)
    Meeting Abstract

    Hendifar, A. E.; Rosen, L. S.; Cercek, A.; McRee, A. J.; Mallick, A. B.; Spigel, D. R.; Tavazoie, S. F.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial
    Meeting Abstract

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Cleary, J. M.; Quinn, D. I.; Brana, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)
    Meeting Abstract

    Harrold, E.; Solter, M.; Walch, H. S.; Chatila, W. K.; Keane, F.; Lumish, M. A.; Yaeger, R.; Weiss, J. A.; Palmaira, R. L.; Krishnan, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save